Minori Yamada

Title: Minori Yamada: Innovator in Monoclonal Antibody Development

Introduction

Minori Yamada is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Minori Yamada holds a patent for a monoclonal antibody, measurement reagent for cytokeratin 18 fragment, reagent kit, and measurement method. The patent discloses an isolated monoclonal antibody comprising a heavy chain and a light chain. The heavy chain includes CDR1, CDR2, and CDR3 consisting of specific amino acid sequences, while the light chain comprises CDR1, CDR2, and CDR3 with its own set of sequences.

Career Highlights

Minori Yamada is associated with Sysmex Corporation, where she has been instrumental in advancing research and development in her field. Her innovative approach has led to the creation of valuable tools for measuring cytokeratin fragments, which are important in various medical diagnostics.

Collaborations

Minori has collaborated with notable colleagues, including Kouji Sakaguchi and Naoya Okitsu. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Sysmex Corporation.

Conclusion

Minori Yamada's contributions to the field of monoclonal antibodies exemplify her dedication to innovation in biotechnology. Her work continues to impact medical diagnostics and therapeutic strategies, showcasing the importance of her inventions in advancing healthcare solutions.